Identification and development of an independent immune-related genes prognostic model for breast cancer

被引:0
作者
Lin Chen
Yuxiang Dong
Yitong Pan
Yuhan Zhang
Ping Liu
Junyi Wang
Chen Chen
Jianing Lu
Yun Yu
Rong Deng
机构
[1] Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University,Department of General Surgery
[2] First Clinical Medical College of Nanjing Medical University,Department of Medical Informatics, School of Biomedical Engineering and Informatics
[3] Nanjing Medical University,undefined
[4] University of Chinese Academy of Sciences,undefined
[5] Nanjing University of Chinese Medicine,undefined
[6] Nanjing Medical University,undefined
来源
BMC Cancer | / 21卷
关键词
Breast cancer; Immune genes; Prognosis; Risk scores model; Nomogram;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 236 条
[1]  
Ferlay J(2015)Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 Int J Cancer 136 E359-E386
[2]  
Soerjomataram I(2008)Triple negative tumours: a critical review Histopathology. 52 108-118
[3]  
Dikshit R(2008)Triple-negative breast cancer: risk factors to potential targets Clin Cancer Res 14 8010-8018
[4]  
Eser S(2016)Risk of regional recurrence in triple-negative breast cancer patients: a Dutch cohort study Breast Cancer Res Treat 156 465-472
[5]  
Mathers C(2011)Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies J Clin Invest 121 2750-2767
[6]  
Rebelo M(2015)Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer Clin Cancer Res 21 1688-1698
[7]  
Parkin DM(2015)New treatment strategies for patients with triple-negative breast cancer Curr Opin Obstet Gynecol 27 77-84
[8]  
Forman D(2014)New strategies for triple-negative breast cancer--deciphering the heterogeneity Clin Cancer Res 20 782-790
[9]  
Bray F(2015)Innate immune recognition of cancer Annu Rev Immunol 33 445-474
[10]  
Reis-Filho JS(2015)Metabolic reprogramming of immune cells in Cancer progression Immunity. 43 435-449